How Delaware became a model for improving cancer control, prevention, and treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

As I step down as medical director of the Helen F. Graham Cancer Center and Research Institute (HFGCCRI) at Christiana Care later this year and assume the position of director of the Cawley Center for Translational Cancer Research at the HFGCCRI, I can reflect back on the success of cancer care in Delaware.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Nicholas J. Petrelli, MD
Bank of America Endowed Medical Director, Helen F. Graham Cancer Center and Research Institute, ChristianaCare Health System; Associate director of translational research, Wistar Cancer Institute
Table of Contents

YOU MAY BE INTERESTED IN

UPMC Hillman Cancer Center at Zabok General Hospital in Croatia is expanding access to the most advanced radiosurgery services for people across the country with the introduction of the Varian TrueBeam stereotactic body radiation therapy and stereotactic radiosurgery system. The new system delivers radiosurgery treatment with pinpoint accuracy and image-guided precision in a shorter amount of time than current conventional treatments.
Nicholas J. Petrelli, MD
Bank of America Endowed Medical Director, Helen F. Graham Cancer Center and Research Institute, ChristianaCare Health System; Associate director of translational research, Wistar Cancer Institute

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login